AVILEX PHARMA ApS
is not in process of liquidation on Nov 19, 2022
Limited liability company
Denmark • 27 Dec 2012 (11 years ago)
Summary
- Normal
Denmark
34896828- Primary:
- #7211 - Research and experimental development on biotechnology
- Description:
- Selskabets formål er udvikling af behandlingsmæssige peptider eller afledte peptider (monomer, dimer og trimer) eller små molekylære forbindelser som er rettet mod PDZ domæner og relateret virksomhed besluttet af bestyrelsen.
Contact details
Officers
Tax information
History
21.12.2018
20.09.2019
30.04.2020
Find out all the information about the company
Get full access to the data
Subdivisions
Find out all the information about the company
Get full access to the data
Related companies by address
Denmark
Ole Maaløes Vej 3, 2200 København N
BGI Europe Institute (Fond)BII Holdings A/SREFLAB ApSHemab ApSMuna Therapeutics ApSBIOREPELLER IVSInnovation Forum CPHBGI DENMARK ApSPhenyx Holding ApSACT.Global A/SLinkbergSterisafe Holding A/SUNIKUM Therapeutics ApSTRT INNOVATIONS APSOLYMPEAK ApSMBB HOLDING 2014 IVSCURASIGHT A/SSolid Therapeutics ApSBioPhenyx ApSRelated companies by officers
Frequently asked questions
Where is AVILEX PHARMA ApS's headquarters?
AVILEX PHARMA ApS's headquarters is located at Ole Maaløes Vej 3, 2200 København N
What is AVILEX PHARMA ApS's industry?
AVILEX PHARMA ApS is in the industry of Research and experimental development on biotechnology
How many employees does AVILEX PHARMA ApS have?
AVILEX PHARMA ApS has 1.58 employees
What year was AVILEX PHARMA ApS started?
AVILEX PHARMA ApS was started in 2012
Your trusted source for business data
English, USA